Investing.com - Financial Markets Worldwide

Implantica AG (IMPsdba)

Stockholm
Currency in SEK
40.70
+0.90(+2.26%)
Real-time Data·
IMPsdba Scorecard
Full Analysis
Analysts anticipate sales growth in the current year
IMPsdba is not included in our AI-picked strategies. See which stocks are.
Fair Value
Unlock Value
Day's Range
39.5041.45
52 wk Range
22.0051.70
Key Statistics
Edit
Prev. Close
39.8
Open
39.75
Day's Range
39.5-41.45
52 wk Range
22-51.7
Volume
58.11K
Average Volume (3m)
47.95K
1-Year Change
34.46%
Book Value / Share
3.8
Fair Value
unlockUnlock
Fair Value Upside
unlockUnlock
IMPsdba Scorecardpro icon
Company’s Health
Unlock
Fair Value
Unlock Price
Fair Price
Upside
Technical Analysis
Neutral
Analysts Sentiment
Buy
Price Target
51.87
Upside
+27.43%
Members' Sentiments
Bearish
Bullish
ProTips
Unlock All 12
Stock generally trades with high price volatility
Unlock InvestingPro

Implantica AG Company Profile

Implantica AG engages in the research and distribution of medical implants in Switzerland. The company’s lead product candidate is RefluxStop, a passive CE-marked implant for prevention of gastroesophageal reflux disease. It focuses on two treatment areas, Gastrointestinal surgery and Urology. It is also involved in the development of eHealth platform, a digital health system to support its pipeline of smart medical implants designed for a safe and secure control and monitoring over the internet; e-InVivo, a sensor implants to monitor a multitude of health parameters and provide diagnostic information, as well as control treatment from inside the body; wireless energizing platform; and AppetiteControl, an implant to treat obesity by controlling appetite. In addition, the company develops UriControl, a hand pumped artificial urinary sphincter to treat urinary incontinence for men and women; and UriRestor, a remote-controlled device that enables spinal cord injury and multiple sclerosis patients to urinate on demand using the wireless platform. Further, it provides PotencyFlow for treatment of erectile dysfunction; StomaRestore for eliminating stoma bags; RectalRestore for treatment of fecal incontinence; and AneurysmControl for monitoring the expansion of the aneurysms. The company was founded in 2015 and is based in Vaduz, Liechtenstein.

Industry
Healthcare Equipment & Supplies
Sector
Healthcare
Employees
50
Market
Sweden

Compare IMPsdba to Peers and Sector

Metrics to compare
IMPsdba
Peers
Sector
Relationship
P/E Ratio
−45.3x−1.5x−0.5x
PEG Ratio
85.12−0.020.00
Price/Book
10.4x1.6x2.6x
Price / LTM Sales
492.8x1.4x3.0x
Upside (Analyst Target)
30.5%121.1%52.6%
Fair Value Upside
Unlock19.4%8.7%Unlock

Analyst Ratings

1 Buy
0 Hold
0 Sell
Ratings:
1 analysts
Overall Consensus
Buy

Analysts 12-Month Price Target:

Average 51.87
(+27.43% Upside)

Earnings

Latest Release
Apr 15, 2025
EPS / Forecast
-0.03 / -1.80
Revenue / Forecast
442.00K / --
EPS Revisions
a
a
Unlock
Last 90 days

IMPsdba Income Statement

FAQ

What Is the Implantica AG (IMPsdba) Stock Price Today?

The Implantica AG stock price today is 40.70

What Stock Exchange Does Implantica AG Trade On?

Implantica AG is listed and trades on the Stockholm Stock Exchange stock exchange.

What Is the Stock Symbol for Implantica AG?

The stock symbol for Implantica AG is "IMPsdba."

What Is the Implantica AG Market Cap?

As of today, Implantica AG market cap is 11.27B.

What Is Implantica AG's Earnings Per Share (TTM)?

The Implantica AG EPS (TTM) is -0.08.

From a Technical Analysis Perspective, Is IMPsdba a Buy or Sell?

Based on moving averages and other technical indicators, the daily buy/sell signal is Neutral.

How Many Times Has Implantica AG Stock Split?

Implantica AG has split 0 times.

How Many Employees Does Implantica AG Have?

Implantica AG has 50 employees.

What is the current trading status of Implantica AG (IMPsdba)?

As of Jun 23, 2025, Implantica AG (IMPsdba) is trading at a price of 40.70, with a previous close of 39.80. The stock has fluctuated within a day range of 39.50 to 41.45, while its 52-week range spans from 22.00 to 51.70.
Install Our App
Risk Disclosure: Trading in financial instruments and/or cryptocurrencies involves high risks including the risk of losing some, or all, of your investment amount, and may not be suitable for all investors. Prices of cryptocurrencies are extremely volatile and may be affected by external factors such as financial, regulatory or political events. Trading on margin increases the financial risks.
Before deciding to trade in financial instrument or cryptocurrencies you should be fully informed of the risks and costs associated with trading the financial markets, carefully consider your investment objectives, level of experience, and risk appetite, and seek professional advice where needed.
Fusion Media would like to remind you that the data contained in this website is not necessarily real-time nor accurate. The data and prices on the website are not necessarily provided by any market or exchange, but may be provided by market makers, and so prices may not be accurate and may differ from the actual price at any given market, meaning prices are indicative and not appropriate for trading purposes. Fusion Media and any provider of the data contained in this website will not accept liability for any loss or damage as a result of your trading, or your reliance on the information contained within this website.
It is prohibited to use, store, reproduce, display, modify, transmit or distribute the data contained in this website without the explicit prior written permission of Fusion Media and/or the data provider. All intellectual property rights are reserved by the providers and/or the exchange providing the data contained in this website.
Fusion Media may be compensated by the advertisers that appear on the website, based on your interaction with the advertisements or advertisers.
© 2007-2025 - Fusion Media Limited. All Rights Reserved.